Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion;IRAD2: Insuffisant respiratoire Á domicile 2 (2e étude) effets d'une réhabilitation à domicile chez l'insuffisant respiratoire chronique dénutri

Revue des Maladies Respiratoires

Volumn 21, Issue 3 I, 2004, Pages 573-582

  Pison, C ^a,c   Cano, N ^b   Cherion C ^a   Roth, H ^a,c   Pichard, C ^d  

^a HÔPITAL MICHALLON   (France)

^b Clinique Residence du Parc   (France)

^c INSERM   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Androgens; Chronic respiratory failure; COPD; Exacerbation; Home; Nutritional depletion; Oral dietary supplements; Pulmonary rhabilitation; Survival; Therapeutic education

Indexed keywords

ANDROGEN; TESTOSTERONE UNDECANOATE;

BICYCLE ERGOMETRY; CHRONIC RESPIRATORY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE EXACERBATION; EXERCISE; FEMALE; HEALTH CARE COST; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUTRITIONAL DEFICIENCY; PATIENT EDUCATION; PROFESSIONAL PRACTICE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL; WALKING; ADULT; ARTICLE; MALNUTRITION; PROSPECTIVE STUDY; RESPIRATORY FAILURE;

ADULT; FEMALE; HOME CARE SERVICES; HUMANS; MALE; MALNUTRITION; PROSPECTIVE STUDIES; RESPIRATORY INSUFFICIENCY;

EID: 3242786353     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(04)71362-5     Document Type: Review

References (87)

1. Charpentier P, Aboiron H: Classification internationales des handicaps. Encycl Med Chir 2000; 26-006-B-10: 1-6.
2. ANTADIR: Observatoire national 1999 de l'ANTADIR de l'insuffisance respiratoire chronique grave. Document ANTADIR 2000.
3. CRAM: Affections longue durée dans la Région Rhône Alpes - Registre 1998. Document CRAM 1999.
4. Sullivan SD, Ramsey SD, Lee TA: The economic burden of COPD. Chest 2000; 117: 5S-9S.
5. Murray CJL, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997; 349: 1498-504.
6. Veale D, Chailleux E, Taytard A, Cardinaud JP: Characteristics and survival of patients prescribed long-term oxygen therapy outside prescription guidelines. Eur Respir J 1998; 12: 780-4.
7. Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM: Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation: A 10-year analysis of ANTADIR Observatory. Chest 1996; 109: 741-9.
8. Chailleux E, Laaban JP, Veale D: Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: Data From the ANTADIR Observatory. Chest 2003; 123: 1460-6.
9. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: Report of the Medical Research Council Working Party. Lancet 1981; 1: 681-6.
10. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial: Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980; 93: 391-8.
11. Leger P, Bedicam JM, Cornette A, Reybetdegat O, Langevin B, Polu JM, Jeannin L, Robert D: Nasal Intermittent Positive Pressure Ventilation - Long-term follow-up in patients with fevere chronic respiratory insufficiency. Chest 1994; 105: 100-5.
12. Okubadejo AA, Jones PW, Wedzicha JA: Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996; 51: 44-7.
13. Okubadejo AA, Paul EA, Jones PW, Wedzicha JA: Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J 1996; 9: 2335-9.
14. Barnes PJ: Novel approaches and targets for treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: S72-S9.
15. Barnes PJ: Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269-80.
16. Celli BR, Cote CG, Marin JM, Casanova C, de Oca MM, Mendez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-12.
17. Cano NJ, Roth H, Court-Ortune I, Cynober L, Gerard-Boncompain M, Cuvelier A, Laaban JP, Melchior JC, Pichard C, Raphael JC, Pison CM and the Clinical Research Group of the Société Francophone de Nutrition Entérale et Parentérale: Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. Eur Respir J 2002; 20: 30-7.
18. Cano NJ, Pichard CI, Roth H, Court-Fortuné I, Cynober L, Gérard-Boncompain M, Cuvelier A, Laaban JP, Melchior JC, Raphaël JC, Pison CM and the Clinical Research Group of the Société Francophone de Nutrition Entérale et Parentérale: C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 2004, in press.
19. Dornhorst AC: Respiratory insufficiency. Lancet 1955; I: 1185-7.
20. Burrows R, Niden AH, Barclay WR, Kasik JE: Chronic obstructive lung disease. II. Relationship of clinical and physiologic findings to the severity of airways obstruction. Am Rev Respir Dis 1965; 91: 665-78.
21. Vandenbergh E, van de Woestijne KP, Gyselen A: Weight changes in the terminal stages of chronic obstructive pulmonary disease. Am Rev Respir Dis 1966; 95: 556-66.
22. Hunter AM, Carey MA, Larsh HW: The nutritional status of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1981; 124: 376-81.
23. Fiaccadori E, Del Canale S, Coffrini E, Vitali P, Antonucci C, Cacciani G, Mazzola I, Guariglia A: Hypercapnic-hypoxemic chronic obstructive pulmonary disease (COPD): influence of severity of COPD on nutritional status. Am J Clin Nutr 1988; 48: 680-5.
24. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF: Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-6.
25. Wilson DO, Rogers RM, Hoffman RM: Nutrition and chronic lung disease. Am Rev Respir Dis 1985; 132: 1347-65.
26. Fitting JW, Spiro SG: Nutritional support in chronic obstructive pulmonary disease. Thorax 1992; 47: 141-3.
27. Pison C, Leverve XM: Mécanismes de la dénutrition au cours de l'insuffisance respiratoire chronique. Nutr Clin Metab 1998; 12: 261-70.
28. Schols AM: Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2000; 6: 110-5.
29. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG: Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 961-6.
30. Dubois P, Jamart J, Machiels J, Smeets F, Lulling J: Prognosis of severely hypoxemic patients receiving long-term oxygen therapy. Chest 1994; 105: 469-74.
31. Decramer M, de B, V, Dom R: Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1958-64.
32. Schols AM, Slangen J, Volovics L, Wouters EF: Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-7.
33. Landbo C, Prescott E, Lange P, Vestbo J, ALMDAL TP: Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-61.
34. Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF: Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994; 7: 1793-7.
35. Rochester DF, Braun NM: Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 132: 42-7.
36. Marcotte JE, Canny GJ, Grisdale R, Desmond K, Corey M, Zinman R, Levison H, Coates AL: Effects of nutritional status on exercise performance in advanced cystic fibrosis. Chest 1986; 90: 375-9.
37. Wilson DO, Rogers RM, Wright EC, Anthonisen NR: Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-8.
38. Schols AM, Mostert R, Soeters PB, Greve LH, Wouters EF: Nutritional state and exercise performance in patients with chronic obstructive lung disease. Thorax 1989; 44: 937-41.
39. Gray-Donald K, Gibbons L, Shapiro SH, Martin JG: Effect of nutritional status on exercise performance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: 1544-8.
40. Newell SZ, Mckenzie DK, Gandevia SC: Inspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitation. Thorax 1989; 44: 903-12.
41. Schols AM, Mostert R, Soeters PB, Wouters EF: Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991; 46: 695-9.
42. Cardenas D, Blonde-Cynober F, Ziegler F, Cano N, Cynober L: Should a single centre for the assay of biochemical markers of nutritional status be mandatory in multicentric trials? Clin Nutr 2001; 20: 553-8.
43. Carlson DJ, Ries AL, Kaplan RM: Prediction of maximum exercise tolerance in patients with COPD. Chest 1991; 100: 307-11.
44. Palange P, Forte S, Felli A, Galassetti P, Serra P, Carlone S: Nutritional state and exercise tolerance in patients with COPD. Chest 1995; 107: 1206-12.
45. Gosselink R, Troosters T, Decramer M: Peripheral muscle weakness contributes to exercise limitation in COPD. AmJ Respir Crit Care Med 1996; 153: 976-80.
46. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G: Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997; 10: 417-23.
47. Pichard C, Genton L, Jolliet P: Measuring body composition: a landmark of quality control for nutritional support services. Curr Opin Clin Nutr Metab Care 2000; 3: 281-4.
48. Kyle UG, Genton L, Slosman DO, Pichard C: Fat free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 years. Nutrition 2001; 17: 534-41.
49. Pichard C, Kyle UG, Slosman DO: Fat-free mass in chronic illness: comparison of bioelectrical impedance and dual-energy x-ray absorptiometry in 480 chronically ill and healthy subjects. Nutrition 1999; 15: 668-6.
50. Kyle UG, Pichard C, Rochat T, Slosman DO, Fitting JW, Thiebaud D: New bioelectrical impedance formula for patients with respiratory insufficiency: comparison to dual-energy X-ray absorptiometry. Eur Respir J 1998; 12: 960-6.
51. Pichard C, Kyle UG: Body composition measurements during wasting diseases. Curr Opin Clin Nutr Metab Care 1998; 1: 357-61.
52. Semple PD, Beastall GH, Watson WS, Hume R: Serum testosterone depression associated with hypoxia in respiratory failure. Clin Sci 1980; 58: 105-6.
53. Semple PD, Beastall GH, Watson WS, Hume R: Hypothalamic-pituitary dysfunction in respiratory hypoxia. Thorax 1981; 36: 605-9.
54. Semple PD, Brown TM, Beastall GH, Semple CG: Sexual dysfunction and erectile impotence in chronic obstructive pulmonary disease. Chest 1983; 83: 587-8.
55. Semple PD, Beastall GH, Brown TM, Stirling KW, Mills RJ, Watson WS: Sex hormone suppression and sexual impotence in hypoxic pulmonary fibrosis. Thorax 1984; 39: 46-51.
56. Sawhney RC, Chhabra PC, Malhotra AS, Singh T, Riar SS, Rai RM: Hormone profiles at high altitude in man. Andrologia 1985; 17: 178-84.
57. Aasebo U, Gyltnes A, Bremnes RM, Aakvaag A, Slordal L: Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long-term oxygen therapy. J Steroid Biochem Mol Biol 1993; 46: 799-803.
58. Creutzberg EC, Wouters EFM, Menheere PP, Schols AMWJ: Plasma free testosterone is related to muscle wasting and impaired physical performance in patients with COPD. Eur Respir J 2000; 16: 29S.
59. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R: The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996; 335: 1-7.
60. Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF: Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995; 152: 1268-74.
61. Ferreira IM, Verreschi IT, Nery LE, Goldstein RS, Zamel N, Brooks D, Jardim JR: The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998; 114: 19-28.
62. Creutzberg EC, Schols AM: Anabolic steroids. Curr Opin Clin Nutr Metab Care 1999; 2: 243-53.
63. Bakhshi V, Elliott M, Gentili A, Godschalk M, Mulligan T: Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc 2000; 48: 550-3.
64. Reynaud-Gaubert M, Pison C, Stern M, Haloun A, Velly JF, Jacquelinet C, Navarro J, Mornex JF: Indications for lung and heart-lung transplantation in adults. Rev Mal Respir 2000; 17: 1119-32.
65. Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH: Randomised controlled trial of respiratory rehabilitation. Lancet 1994; 344: 1394-7.
66. Ries AL, Kaplan RM, Limberg TMK, Prewitt LM: Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122: 823-32.
67. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS: Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115-9.
68. Lacasse Y, Guyatt GH, Goldstein RS: The components of a respiratory rehabilitation program: A systematic overview. Chest 1997; 111: 1077-88.
69. Donner CF, Muir JF, Clark CJ, Grunze M, Prefaut C, Sergysels R, Wouters EFM, Zuwallack RL: Selection criteria and programmes for pulmonary rehabilitation in COPD patients. Eur Respir J 1997; 10: 744-57.
70. AACVP/AACVPR: Joint ACCP/AACVPR evidence-based guidelines. Chest 1997; 112: 1363-96.
71. Casaburi R, Porszasz J, Burns MR, Carithers ER, Chang RSY, Cooper CB: Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 1541-51.
72. ATS: Pulmonary rehabilitation. Am J Respir Crit Care Med 1999; 159: 1666-82.
73. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Lonescu AA, Thomas J, Tunbridge J: Results at 1 year of outpatient multidisciplinary pulmonary ré habilitation: a randomised controlles trial. Lancet 2000; 355: 362-8.
74. Foster S, Lopez D, Thomas HM: Pulmonary rehabilitation in COPD patients with elevated PCO2. Am Rev Respir Dis 1988; 138: 1519-23.
75. Wedzicha JA, Bestall JC, Garrod R, Garnham R, Paul EA, Jones PW: Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J 1998; 12: 363-9.
76. Rodriguez-Roisin R: Toward a consensus definition for COPD exacerbations. Chest 2000; 117: 398S-401S.
77. Gautier V, Serres I, Fuchs-Clement D, Hayot M, Préfaut C: Respiratory rehabilitation in chronic obstructive pulmonary disease (COPD) outpatients under long term oxygenotherapy (LTOT). Eur Respir J 2001; 7: 393S.
78. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D: Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999; 160: 1248-53.
79. Garrod R, Mikelsons C, Paul EA, Wedzicha JA: Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1335-41.
80. Debigare R, Maltais F, Whittom F, Deslauriers J, Leblanc P: Feasibility and efficacy of home exercise training before lung volume reduction. J Cardiopulm Rehabil 1999; 19: 235-41.
81. Strijbos JH, Postma DS, Vanaltena R, Gimeno F, Koeter GH: A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD: a follow-up of 18 months. Chest 1996; 109: 366-72.
82. Wijkstra PJ, Vandermark TW, Kraan J, Vanaltena R, Koeter GH, Postma DS: Long-term effects of home rehabilitation on physical performance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1234-41.
83. Debigare R, Maltais F, Mallet M, Casaburi R, Leblanc P: Influence of work rate incremental rate on the exercise responses in patients with COPD. MedSci Sports Exerc 2000; 32: 1365-8.
84. Guyatt GH, Berman LB, Townsend M, Pugssleey SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-8.
85. Guimont C, Bourbeau J: Dyspnea assessed by the chronic respiratory questionnaire in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 151: A466.
86. Carone M, Bertolotti G, Anchisi F, Zotti AM, Donner CF, Jones PW: Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of life in chronic respiratory failure group. Eur Respir J 1999; 13: 1293-300.
87. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS: Nutritional intervention in COPD. A systematic overview. Chest 2001; 119: 353-63.